Apoptosis-Inducing and Proliferation-Inhibiting Effects of Doramectin on Mz-ChA-1 Human Cholangiocarcinoma Cells
Yunfang Zhang, Wei Wu, Yan Shi, Yuehong Huang, Ting Dai, Lina Ke, Lizhu Chen, Mingliang Chen, Qin Wang · 2024
Read Apoptosis-Inducing and Proliferation-Inhibiting Effects of Doramectin on Mz-ChA-1 Human Cholangiocarcinoma Cells by Yunfang Zhang, Wei Wu, Yan Shi, Yuehong Huang, Ting Dai, Lina Ke, Lizhu Chen, Mingliang Chen, Qin Wang (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11676298.txt.
Description
Yunfang Zhang and co-authors test an animal worming drug against a bile duct cancer in the lab, in a 2024 paper. Cholangiocarcinoma arises in the bile ducts and is hard to treat. Doramectin, a refined member of the avermectin drug family, is known for low toxicity and strong effect against parasites. No one had checked whether it also fights this cancer, so the team worked with human cancer cells grown in dishes.
The drug slowed the cells' growth in step with the dose and cut their ability to migrate and invade. It stalled them at the cell cycle's first checkpoint, raising one brake protein and lowering two drivers. It also pushed cells into programmed death through the mitochondria, raising stress signals and death enzymes. Gene-readout analysis plus direct tests map how the old veterinary drug squeezes this cancer from several sides.
Catalog record
| CREATOR | Yunfang Zhang, Wei Wu, Yan Shi, Yuehong Huang, Ting Dai, Lina Ke, Lizhu Chen, Mingliang Chen, Qin Wang |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 26 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |